These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

555 related articles for article (PubMed ID: 34227079)

  • 21. The Fatigue-Related Symptoms Post-Acute SARS-CoV-2: A Preliminary Comparative Study.
    Thomas M
    Int J Environ Res Public Health; 2022 Sep; 19(18):. PubMed ID: 36141935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Post-COVID syndrome-Focus fatigue].
    Hellwig S; Domschke K
    Nervenarzt; 2022 Aug; 93(8):788-796. PubMed ID: 35606656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Historical Insight into Infections and Disorders Associated with Neurological and Psychiatric Sequelae Similar to Long COVID.
    Stefano GB
    Med Sci Monit; 2021 Feb; 27():e931447. PubMed ID: 33633106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inequity and disparities mar existing global research evidence on Long COVID.
    Taghrir MH; Akbarialiabad H; Abdollahi A; Ghahramani N; Bastani B; Paydar S; Razani B; Mwangi J; Asadi-Pooya AA; Roozbeh J; Malekmakan L; Kumar M
    Glob Health Promot; 2023 Mar; 30(1):63-67. PubMed ID: 35962520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccination Hesitancy and Postacute Sequelae of SARS-CoV-2: Is It Time to Reconsider?
    Arnold CG; Monte AA; Littlefield K; Vest A; Palmer BE
    Viral Immunol; 2021 Dec; 34(10):666-668. PubMed ID: 34491119
    [No Abstract]   [Full Text] [Related]  

  • 26. Association of SARS-CoV-2 Seropositivity With Myalgic Encephalomyelitis and/or Chronic Fatigue Syndrome Among Children and Adolescents in Germany.
    Sorg AL; Becht S; Jank M; Armann J; von Both U; Hufnagel M; Lander F; Liese JG; Niehues T; Verjans E; Wetzke M; Stojanov S; Behrends U; Drosten C; Schroten H; von Kries R
    JAMA Netw Open; 2022 Sep; 5(9):e2233454. PubMed ID: 36166227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Addressing the post-acute sequelae of SARS-CoV-2 infection: a multidisciplinary model of care.
    Parker AM; Brigham E; Connolly B; McPeake J; Agranovich AV; Kenes MT; Casey K; Reynolds C; Schmidt KFR; Kim SY; Kaplin A; Sevin CM; Brodsky MB; Turnbull AE
    Lancet Respir Med; 2021 Nov; 9(11):1328-1341. PubMed ID: 34678213
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proposed subtypes of post-COVID-19 syndrome (or long-COVID) and their respective potential therapies.
    Yong SJ; Liu S
    Rev Med Virol; 2022 Jul; 32(4):e2315. PubMed ID: 34888989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Editorial: Long COVID, or Post-COVID Syndrome, and the Global Impact on Health Care.
    Parums DV
    Med Sci Monit; 2021 Jun; 27():e933446. PubMed ID: 34092779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postacute Sequelae of COVID-19 Critical Illness.
    Schwab K; Schwitzer E; Qadir N
    Crit Care Clin; 2022 Jul; 38(3):455-472. PubMed ID: 35667737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Follow-up of COVID-19 recovered patients with mild disease.
    Kashif A; Chaudhry M; Fayyaz T; Abdullah M; Malik A; Anwer JMA; Inam SHA; Fatima T; Iqbal N; Shoaib K
    Sci Rep; 2021 Jun; 11(1):13414. PubMed ID: 34183705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long COVID and post-acute sequelae of SARS-CoV-2 pathogenesis and treatment: A Keystone Symposia report.
    Durstenfeld MS; Weiman S; Holtzman M; Blish C; Pretorius R; Deeks SG
    Ann N Y Acad Sci; 2024 May; 1535(1):31-41. PubMed ID: 38593220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with Long COVID/Post-Acute Sequelae of COVID-19 (PASC).
    Pretorius E; Venter C; Laubscher GJ; Kotze MJ; Oladejo SO; Watson LR; Rajaratnam K; Watson BW; Kell DB
    Cardiovasc Diabetol; 2022 Aug; 21(1):148. PubMed ID: 35933347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-COVID fatigue is not predicted by pre-pandemic plasma IL-6 levels in mild COVID-19.
    Freidin MB; Cheetham N; Duncan EL; Steves CJ; Doores KJ; Malim MH; Rossi N; Lord JM; Franks PW; Borsini A; Granville Smith I; Falchi M; Pariante C; Williams FMK
    Inflamm Res; 2023 May; 72(5):947-953. PubMed ID: 36995412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Post-COVID-19 Syndrome: Theoretical Basis, Identification, and Management.
    Scordo KA; Richmond MM; Munro N
    AACN Adv Crit Care; 2021 Jun; 32(2):188-194. PubMed ID: 33942071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Post covid 19 pulmonary fibrosis. Is it real threat?
    Rai DK; Sharma P; Kumar R
    Indian J Tuberc; 2021 Jul; 68(3):330-333. PubMed ID: 34099197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Causation or confounding: why controls are critical for characterizing long COVID.
    Amin-Chowdhury Z; Ladhani SN
    Nat Med; 2021 Jul; 27(7):1129-1130. PubMed ID: 34140704
    [No Abstract]   [Full Text] [Related]  

  • 38. Long COVID and its Management.
    Koc HC; Xiao J; Liu W; Li Y; Chen G
    Int J Biol Sci; 2022; 18(12):4768-4780. PubMed ID: 35874958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long Covid: where we stand and challenges ahead.
    Mantovani A; Morrone MC; Patrono C; Santoro MG; Schiaffino S; Remuzzi G; Bussolati G;
    Cell Death Differ; 2022 Oct; 29(10):1891-1900. PubMed ID: 36071155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long COVID Citizen Scientists: Developing a Needs-Based Research Agenda by Persons Affected by Long COVID.
    Ziegler S; Raineri A; Nittas V; Rangelov N; Vollrath F; Britt C; Puhan MA
    Patient; 2022 Sep; 15(5):565-576. PubMed ID: 35478078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.